BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14633477)

  • 1. Postmenopausal hormones. Hormone therapy: what happened? Our assumptions about taking hormones after menopause have mostly been dashed. How did we get it so wrong?
    Harv Womens Health Watch; 2003 Nov; 11(3):2-4. PubMed ID: 14633477
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of metabolism on the safety of estrogen therapy.
    Prokai-Tatrai K; Prokai L
    Ann N Y Acad Sci; 2005 Jun; 1052():243-57. PubMed ID: 16024767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy. A year in review.
    Mayo Clin Womens Healthsource; 2003 Aug; 7(8):1-2. PubMed ID: 12925832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The menopause: benefits and risks of hormone replacement therapy.
    Gambrell RD
    Compr Ther; 1994; 20(10):580-5. PubMed ID: 7859441
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone in the hot seat.
    Mandavilli A
    Nat Med; 2006 Jan; 12(1):8-9. PubMed ID: 16397539
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormone replacement therapy in the climacteric--from hallelujah to requiem].
    Odlind V
    Lakartidningen; 2004 Jun; 101(26-27):2264-9. PubMed ID: 15281626
    [No Abstract]   [Full Text] [Related]  

  • 8. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
    Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good science or good marketing?
    Head K
    Altern Med Rev; 2002 Aug; 7(4):274-5. PubMed ID: 12197780
    [No Abstract]   [Full Text] [Related]  

  • 10. Postmenopausal hormones: where do we go from here?
    Harv Womens Health Watch; 2003 Jan; 10(5):3-4. PubMed ID: 12543588
    [No Abstract]   [Full Text] [Related]  

  • 11. Termination of the oestrogen-alone arm of the Women's Health Initiative.
    Stevenson J; Rees M; Marsden J
    J Br Menopause Soc; 2004 Jun; 10(2):47, 59. PubMed ID: 15759323
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
    Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S
    Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.
    Brown S
    Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations on hormone replacement therapy: an answer to the 'one dose fits all' Women's Health Initiative study.
    Studd J
    Gynecol Endocrinol; 2007 Nov; 23(11):665-71. PubMed ID: 17943531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us?
    Sherwin BB
    Ann N Y Acad Sci; 2005 Jun; 1052():3-10. PubMed ID: 16024746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
    Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's Health Initiative: not over yet. The largest study of women's health has raised at least as many questions as it has answered. Stay tuned.
    Harv Womens Health Watch; 2006 May; 13(9):1-4. PubMed ID: 16696133
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials report. Risks and benefits of hormone replacement therapy.
    Kotchen TA; Mansour G; Mansour AJ
    Curr Hypertens Rep; 2003 Dec; 5(6):483-4. PubMed ID: 14594567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.